| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 07/15/2004 | US20040137080 Multivitamin regimen for renal patients |
| 07/15/2004 | US20040137079 A stable aqueous solution of hyaluronic acid, a stabilized oxy-chloro complex, e.g., chlorine dioxide, a boric acid/borate buffer to maintain a pH of 6-9 and no more than 0.0075% hydrogen peroxide; storage; conditioning; increased comfort; dry eye |
| 07/15/2004 | US20040137078 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/15/2004 | US20040137077 Seborrheic keratosis treatment |
| 07/15/2004 | US20040137076 Antibacterial processing of fiber products |
| 07/15/2004 | US20040137072 Reducing the risk of osteoporosis and other bone-loss disorders in females; increases the bioavailability of metabolites involved in bone mineral loss and calcium absorption control |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |
| 07/15/2004 | US20040137037 gel comprising a protein that does not coagulate at pH 3 to 4; calcium; acid; carbohydrate; fat; emulsifier; agar; and water; food; nutraceutical; increasing blood (plasma) volume for improved excercise endurance, heat tolerance |
| 07/15/2004 | US20040137029 modifying a mineral supplement or animal feed through the addition of effective amounts of garlic and sulfur as insect repellant |
| 07/15/2004 | US20040137022 administration of effective amounts of manganese or salts to individuals suffering from skin color defficiency due to stress, positively affects the calcium channels to relax or slacken cutaneous vascular tissues and thus combats skin pallor |
| 07/15/2004 | US20040136905 Magnetically guided particles for radiative therapies |
| 07/15/2004 | US20040136904 Dry powder compositions comprising labelled particles for inhalation |
| 07/15/2004 | DE202004006157U1 Pharmaceutical or dietetic product useful for treating headache and migraine comprises a blueberry extract together with vitamins and minerals |
| 07/15/2004 | CA2511440A1 Reduction of reactive oxygen species in chronic wound management |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | CA2453053A1 Use of n2o in the treatment of post-ischemic deterioration of brain cells |
| 07/14/2004 | EP1437140A1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 07/14/2004 | EP1437126A1 Compositions used to alleviate xerostomia and to treat disorders associated with same |
| 07/14/2004 | EP1437052A1 Ocuvite Zinc |
| 07/14/2004 | EP1436018A1 Nitric oxide-releasing coated medical devices and method of preparing same |
| 07/14/2004 | EP1436010A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436000A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 07/14/2004 | EP1435988A1 Improved use of antitumoral compound in cancer therapy |
| 07/14/2004 | EP1435971A1 Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs) |
| 07/14/2004 | EP1435965A2 Pharmaceutical compositions and methods for treating cancer |
| 07/14/2004 | EP1435963A2 Reduced toxicity cisplatin formulations and methods for using the same |
| 07/14/2004 | EP1435937A2 Composition comprising paracetamol and a bitterness masking component |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435897A2 Ultra fine dead sea mineral compound and method of manufacture |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1282391B1 High cleaning dentifrice |
| 07/14/2004 | EP1202996B9 Titanium derived compounds, preparation and use thereof |
| 07/14/2004 | EP1079799B1 Use of an antimicrobial agent |
| 07/14/2004 | CN1512887A Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 07/14/2004 | CN1511541A Use of sodium selenite in producing medicine |
| 07/14/2004 | CN1157227C Use of low molecular weight amino alcohols in ophthalmic compositions |
| 07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
| 07/14/2004 | CN1157214C Pure Chinese medicine prepn for treating psychosis |
| 07/14/2004 | CN1157207C Chinese medicine with physique enhancing and disease treating functions and its producing process |
| 07/14/2004 | CN1157205C Ointment for treating ostalgia |
| 07/14/2004 | CN1157204C Mother liquid medicine for treating liver cancer and its preparing process |
| 07/14/2004 | CN1157193C Lotion for treating anal fistula and gynopathy |
| 07/14/2004 | CN1157183C Calamine lotion |
| 07/13/2004 | US6761912 Composition for increasing bone density |
| 07/13/2004 | US6761911 Use of chlorate ion or preparations thereof for reduction of food borne pathogens |
| 07/13/2004 | US6761879 Titanium derived compounds, preparation and use thereof |
| 07/13/2004 | US6761873 Dialysis |
| 07/13/2004 | CA2067062C Infusion preparation |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056375A1 Agent for decreasing appetite and for producing a satiation effect, for reducing weight and for lowering the cholesterol level |
| 07/08/2004 | WO2004056323A2 Method of treating angiogenic tissue growth |
| 07/08/2004 | WO2004043393A3 Compositions for diabetes treatment and prophylaxis |
| 07/08/2004 | WO2004009072B1 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 07/08/2004 | WO2003093322A9 Carrageenan based antimicrobial compositions |
| 07/08/2004 | US20040132739 e.g. RO 28-2653 in combination with Cisplatin, Paclitaxel, Gemcitabine or Etoposide; treating patients with solid metastasized or non-metastasized tumors |
| 07/08/2004 | US20040132689 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid |
| 07/08/2004 | US20040131707 an aqueous Soma, comprising apple cider vinegar, quinine, blackstrap molasses, sulfur, and whole milk; suited for treating lymphoid malignancies |
| 07/08/2004 | US20040131706 Pharmaceutical preparation |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131700 Prevent plaque forming in tissue |
| 07/08/2004 | US20040131698 Methods of treating conditions using metal-containing materials |
| 07/08/2004 | US20040131697 Oral compositions for the treatment of obese non-diabetic mammals, including humans |
| 07/08/2004 | US20040131696 Administering aluminum compound complexed to polyoxyalkylene glycol |
| 07/08/2004 | US20040131695 Use of an aqueous solution in the treatment of live animals |
| 07/08/2004 | US20040131688 Mixture of biological tissue, particles and confining liquid; stability; three-dimensional; absorption, decomposition of toxicity ; encapsulation of bacteria |
| 07/08/2004 | US20040131646 Gel delivery vehicles for anticellular proliferative agents |
| 07/08/2004 | US20040131643 Immune response potentiation |
| 07/08/2004 | US20040129638 Multi-part substitution infusion fluids and matching anticoagulants |
| 07/08/2004 | US20040129112 Metal-containing materials |
| 07/08/2004 | DE10259506A1 Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable |
| 07/08/2004 | DE10257478A1 Composition containing antioxidants and micronutrients, useful for treatment or prevention of paradontitis and associated disorders, also osteoporosis |
| 07/08/2004 | CA2510780A1 Method of treating angiogenic tissue growth |
| 07/07/2004 | EP1267816A4 The use of xanthan gum for gelling cio 2 and related species |
| 07/07/2004 | EP1006794A4 A method for treating or preventing alzheimer's disease |
| 07/07/2004 | EP0759749B1 Anti-acne compositions |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1509752A Medicine for treating skin chap, and preparing method thereof |
| 07/07/2004 | CN1156292C Medicine for curing cholecystitis and its preparing method |
| 07/07/2004 | CN1156287C Composite medicine for treating myocardosis |
| 07/07/2004 | CN1156284C Chinese Medicine for treating hepatism |
| 07/07/2004 | CN1156269C Liposome composition having resistance to freeze/thaw damage |
| 07/06/2004 | US6759437 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759397 Ginsenoside chemotherapy |
| 07/06/2004 | US6759062 Composition and method for treating the effects of diseases and maladies |
| 07/06/2004 | US6759045 Administering antibodies; anticancer agents |
| 07/06/2004 | US6759033 Method for slowing the decomposition of a cosmetic composition |
| 07/06/2004 | US6758214 Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
| 07/01/2004 | WO2004054499A2 Platinum aggregates and process for producing the same |
| 07/01/2004 | WO2004054390A1 Methods of using a beverage composition |
| 07/01/2004 | WO2004032979A3 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto |
| 07/01/2004 | WO2004026239A3 Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| 07/01/2004 | WO2003092763A8 Carbon nanotubules for storage of nitric oxide |
| 07/01/2004 | WO2003072048A3 Symptomatic relief of gastrointestinal disorders |
| 07/01/2004 | US20040127568 Therapeutic use of D-methionine to reduce the toxicity of radiation |
| 07/01/2004 | US20040127539 Antiangiogenic combination therapy for the treatment of cancer |
| 07/01/2004 | US20040127470 Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| 07/01/2004 | US20040127437 Combined therapeutical treatment of hyperproliferative diseases |